Alpha Windward LLC increased its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 35.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,981 shares of the company’s stock after purchasing an additional 787 shares during the period. Alpha Windward LLC’s holdings in Express Scripts were worth $223,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Nordea Investment Management AB raised its holdings in Express Scripts by 1.4% during the second quarter. Nordea Investment Management AB now owns 7,116,445 shares of the company’s stock worth $454,314,000 after purchasing an additional 97,953 shares in the last quarter. Van ECK Associates Corp raised its holdings in Express Scripts by 5.1% during the third quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock worth $32,072,000 after purchasing an additional 24,728 shares in the last quarter. Lazard Asset Management LLC raised its holdings in Express Scripts by 81.8% during the second quarter. Lazard Asset Management LLC now owns 112,666 shares of the company’s stock worth $7,192,000 after purchasing an additional 50,707 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of Express Scripts by 12.5% in the third quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock valued at $2,243,000 after buying an additional 3,940 shares in the last quarter. Finally, Marco Investment Management LLC bought a new position in shares of Express Scripts in the second quarter valued at $1,797,000. 88.21% of the stock is currently owned by hedge funds and other institutional investors.
Express Scripts Holding (NASDAQ ESRX) opened at $80.22 on Friday. Express Scripts Holding has a 52-week low of $55.80 and a 52-week high of $81.75. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The firm has a market cap of $45,310.00, a P/E ratio of 13.33, a price-to-earnings-growth ratio of 0.89 and a beta of 0.87.
Express Scripts declared that its board has approved a stock repurchase plan on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.
In other news, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the stock in a transaction dated Tuesday, October 31st. The shares were bought at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the acquisition, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 17,644 shares of company stock worth $1,289,609. Corporate insiders own 0.68% of the company’s stock.
Several research firms have issued reports on ESRX. Mizuho set a $67.00 price target on Express Scripts and gave the company a “hold” rating in a report on Tuesday, October 24th. Raymond James Financial reaffirmed a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Evercore ISI began coverage on Express Scripts in a report on Thursday, January 4th. They issued an “in-line” rating and a $78.00 price target on the stock. Robert W. Baird reaffirmed a “buy” rating and issued a $92.00 price target (up previously from $81.00) on shares of Express Scripts in a report on Tuesday, January 9th. Finally, Sanford C. Bernstein raised Express Scripts from an “underperform” rating to a “market perform” rating in a report on Wednesday, December 6th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $77.09.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding (ESRX) Position Raised by Alpha Windward LLC” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://sportsperspectives.com/2018/01/20/express-scripts-holding-esrx-position-raised-by-alpha-windward-llc.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.